NC State Poole College announces speakers for 10th annual Biosciences Forum

Submitted by Anna Rzewnicki on Thursday Oct 09, 2014.

The Biosciences Management Initiative in the NC State Poole College of Management is hosting its 10th Annual Biosciences Forum on November 7, 2014, at the North Carolina Biotechnology Center, 15 T.W. Alexander Drive, Research Triangle Park, NC. View directions here.

The forum begins with a continental breakfast at 7:00 a.m., with the program beginning at 7:30 a.m. and concluding at 12:00 p.m. There is no charge to attend but registration is required.

The featured presenters at the 2014 Biosciences Forum are:

  • David Pulman, president (retired), Global Manufacturing & Supply, GlaxoSmithKline, Research Triangle Park, N.C.
    TOPIC: "Personal development from penicillin"
  • Sergi Roura, president, Grifols Therapeutics, Inc., Clayton, N.C.
    TOPIC: "Grifols and the plasma industry"
  • Peter Marks, deputy director, Center for Biologics Evaluation and Research, FDA, Raleigh, N.C.
    TOPIC: "Balancing benefit, risk and uncertainty in the assessment of novel medical product"

Concluding the program will be a presentation by Richard Kouri, professor of practice and director of the Biosciences Management Initiative at the NC State Poole College of Management, and Paul Mugge, director of the Center for Innovation Management Studies based in Poole College. Their topic is: "A new way to use decision analytics – follow the money."

The Bioscience Forum has been held at NCBC’s auditorium each year, providing easy access for those working in the Triangle region.

“On behalf of Poole College, I thank the North Carolina Biotechnology Center for so generously hosting this annual forum,” said Ira Weiss, dean and Stephen P. Zelnak Jr. Chair at the Poole College of Management. “This has provided a tremendous opportunity for our students and members of the Triangle’s biosciences community to receive industry updates and to continue building their professional network.”

“The annual forum also provides a great venue for showcasing our graduate students’ practicum projects,” said Kouri, who teaches in the NC State Jenkins MBA program’s biosciences management concentration and coordinates student practicum projects.

Over the past ten years, nearly 200 graduate students in the biosciences management concentration have worked on more than 65 projects with 40-plus companies. The students and their company mentors have worked on a range of business challenges and opportunities, including market analysis, measuring innovation, quality management, packaging, tech mining, sustainability, and strategy, in North Carolina’s Research Triangle Park as well as University College Dublin in Ireland.

A number of the students will be available to discuss their practicum projects from the past year during the BioSciences Forum’s poster gallery session.

“We are very excited to be celebrating our 10th Annual Biosciences Forum,” Kouri said. The forum typically draws over 200 attendees representing the range of biosciences industries in the RTP, as well as current students and alumni of the program. “We are especially inviting our biosciences concentration alumni to join us for this event,” he said.


President (retired), GlaxoSmithKline, Research Triangle Park, N.C.

In the last 10 years of his 35-year career with GlaxoSmithKline, David Pulman served as president of GSK’s global manufacturing and supply, with responsibility for the supply of pharmaceuticals, biopharmaceuticals and consumer health products. Operations were situated in 40 countries with an internal manufacturing network of 80 sites in addition to a substantial external network.

Pulman’s management focus was on delivering a strong fundamental quality, compliance, safety, environmental and supply performance, including improvement programs that increased productivity by 70 percent over the course of his tenure as president. He also chaired GSK’s philanthropic committee, the Children’s Health Fund Corporate council, and is a non-executive director of FM Global and the Board of New Schools, a North Carolina-based education not-for-profit. His current interests include understanding the factors that influence organizational and personal excellence, modern traits in the global society and how to redefine the productive lifestyle in the post employment environment.

GSK is a science-led global healthcare company with commercial operations in more than 150 countries, a network of manufacturing sites in 36 countries and large R&D centers in the UK, USA, Spain, Belgium and China. Its vaccines business is one of the largest in the world, and the company develops and markets a range of consumer healthcare products in the categories of wellness, oral health, skin health and nutrition. Read more about GSK.

President of Grifols Therapeutics, Inc., Clayton, N.C.

As president of Grifols Therapeutics Inc., Sergi Roura is responsible for the oversight and planning of the company’s manufacturing operations in Clayton, N.C. The new 155,000 square-foot facility, which was opened in June 2014, is one of the largest capital projects in Johnston County and will be one of the world’s most technologically advanced plasma fraction facilities. He brings to this role extensive manufacturing operations expertise and an industrial engineering background. He also serves as president of Probitas Fundacion, a private non-profit organization founded in 2008 by Grifols to improve medical attention in countries with limited resources through its experience and knowledge in the health sector.

Grifols is a global healthcare company that produces life-saving protein therapies for patients and provides hospitals, pharmacies and healthcare professionals products needed to deliver expert medical care. The company has been working in the fields of transfusion, blood banking, protein therapeutics and laboratory analysis for more than 70 years. Read more about Grifols.

Deputy Director, Center for Biologics Evaluation and Research, FDA, Raleigh, N.C. 

Vaccines, blood, and biologics are regulated by FDA's Center for Biologics Evaluation and Research (CBER), which also provides the public with information to promote the safe and appropriate use of these products.

Peter Marks joined the FDA center in 2012, after working as both a hospital physician and in the pharmaceutical industry. Marks received his graduate degree in cell and molecular biology and his medical degree at New York University. He then completed an internal medicine residency and a hematology/medical oncology fellowship at Brigham and Women’s Hospital in Boston, where he subsequently joined the attending staff as a clinician-scientist and eventually served as clinical director of hematology. Marks then worked for several years in the pharmaceutical industry on the clinical development of hematology and oncology products prior to returning to academic medicine at Yale University where he led the Adult Leukemia Service and served as chief clinical officer of Smilow Cancer Hospital, prior to joining the FDA FDA's Center for Biologics Evaluation and Research. Read more about the FDA.


We thank our sponsors for this event. Additional sponsorship opportunities are available. Please contact Richard Kouri to discuss options.

  • Syngenta | Silver Sponsor
  • The Hamner Institutes 


Upcoming Events

View Grad ECON Events

Learn More »


Read the latest EcoNews

Learn More »